Study Finds Buspirone Often Prescribed Off-Label and Potentially Under-Dosed in Psychiatric Settings

A recent study examines how often doctors prescribe buspirone in psychiatric settings, and it also looks at the typical dosages they use. The research focuses on whether the way buspirone is being prescribed aligns with the existing scientific evidence about the drug. Findings suggest buspirone is frequently prescribed for uses that the Food and Drug Adminstration has not approved. The findings also indicate that doctors may not be using optimal dosages for the medicine to be fully effective. Researchers found that many buspirone prescriptions were for conditions other than its approved use for anxiety disorders. The research also showed a trend toward using dosages that may be lower than what’s typically considered effective based on clinical trials and established guidelines. The study highlights a need for more careful consideration of evidence-based practices when prescribing buspirone in psychiatric settings.

Newsflash | Powered by GeneOnline AI
Date: May 3, 2025

Related posts:

Study Reveals Cognitive Decline Linked to Low-Normal Vitamin B12 Levels Roger Perlmutter’s New Biotech Startup Secures $350 Million in Funding Breakthrough in Cancer Vaccine Development Enhances Effectiveness and Reach Anne Wojcicki’s Bold Move to Reclaim 23andMe Sparks Debate in Biotech Industry

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後